Scholarlink

<p>Alport syndrome (AS) is the second-most frequent monogenic kidney disease and 85% of cases are caused by mutations in the genes of the α5 chains of collagen type IV (<i>COL4A5</i>). The early diagnosis and treatment are essential for the prognosis of AS. The clinical phenotypes of AS are very variable, which is challenging to diagnose. Genetic diagnosis is sensitive and accurate, which can recognize the affected individuals with mild phenotype for early diagnosis and predict the age at renal failure for early treatment. In addition, genetic testing will offer the available reproductive options, including prenatal diagnosis and preimplantation genetic testing (PGT). In this study, three novel <i>COL4A5</i> variants (c.1834G &gt; T, c.865G &gt; A and c.1032 + 5G &gt; A) were found. These variants co-segregated with the disease in multiple affected family members. In vitro splicing assay indicated that the c.1032 + 5G &gt; A variant resulted in aberrant splicing involving exon 18 skipping. The healthy babies without these novel <i>COL4A5</i> variants were born by PGT or prenatal diagnosis, respectively. Three novel variants in <i>COL4A5</i> gene can provide insights into further genetic counseling or genotype–phenotype correlations.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Identification of novel COL4A5 variants and prenatal diagnosis in three large families

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年3月8日

查看全文
  • Baitao Zeng,
  • Yao Yu,
  • Cong Liu,
  • Xinyu Li,
  • Qing Lu,
  • Zhongfa Chen,
  • Jia Chen,
  • Jun Zou,
  • Bicheng Yang,
  • Yanqiu Liu,
  • Yongyi Zou

摘要

Alport syndrome (AS) is the second-most frequent monogenic kidney disease and 85% of cases are caused by mutations in the genes of the α5 chains of collagen type IV (COL4A5). The early diagnosis and treatment are essential for the prognosis of AS. The clinical phenotypes of AS are very variable, which is challenging to diagnose. Genetic diagnosis is sensitive and accurate, which can recognize the affected individuals with mild phenotype for early diagnosis and predict the age at renal failure for early treatment. In addition, genetic testing will offer the available reproductive options, including prenatal diagnosis and preimplantation genetic testing (PGT). In this study, three novel COL4A5 variants (c.1834G > T, c.865G > A and c.1032 + 5G > A) were found. These variants co-segregated with the disease in multiple affected family members. In vitro splicing assay indicated that the c.1032 + 5G > A variant resulted in aberrant splicing involving exon 18 skipping. The healthy babies without these novel COL4A5 variants were born by PGT or prenatal diagnosis, respectively. Three novel variants in COL4A5 gene can provide insights into further genetic counseling or genotype–phenotype correlations.